Cargando…

The Impact of COVID-19 on Liver Injury

The current coronavirus disease outbreak of 2019 (COVID-19) has led to a global pandemic. The principal cause of mortality in COVID-19 is represented lung injury with the development of acute respiratory distress syndrome (ARDS). In patients with COVID-19 infection, liver injury or liver dysfunction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dawood, Dr. Reham M., Salum, Ghada Maher, El-Meguid, Mai Abd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Southern Society for Clinical Investigation. Published by Elsevier Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571104/ https://www.ncbi.nlm.nih.gov/pubmed/34752738 http://dx.doi.org/10.1016/j.amjms.2021.11.001

Ejemplares similares

Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation
por: Salum, Ghada M., et al.
Publicado: (2021)

Bioinformatics analysis of multi-epitope peptide vaccines against Hepatitis C virus: a molecular docking study
por: Muhammad, Ashraf M., et al.
Publicado: (2023)

Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study
por: Dawood, Reham M, et al.
Publicado: (2021)

Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients
por: Dawood, Reham M., et al.
Publicado: (2022)

Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
por: Salum, Ghada M., et al.
Publicado: (2019)

Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2
por: Dawood, Reham M., et al.
Publicado: (2021)

The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection
por: Dawood, Reham M, et al.
Publicado: (2022)

Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis
por: Ibrahim, Marwa K., et al.
Publicado: (2016)

HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma
por: Abd Alla, Mohamed Darwish Ahmed, et al.
Publicado: (2023)

COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells
por: Ali, Fares E M, et al.
Publicado: (2023)

COVID-19-Associated Liver Injury
por: Gildea, Daniel T, et al.
Publicado: (2023)

Can MRI diffusion-weighted imaging identify postoperative residual/recurrent soft-tissue sarcomas?
por: ElDaly, Mai Maher, et al.
Publicado: (2018)

Characteristics of suicidal poisoned patients admitted to tertiary care center during COVID-19 pandemic
por: El-Sarnagawy, Ghada, et al.
Publicado: (2022)

Polymorphism in Variable Number of Tandem Repeats of Dopamine D4 Gene Is a Genetic Risk Factor in Attention Deficit Hyperactive Egyptian Children: Pilot Study
por: Shahin, Ola, et al.
Publicado: (2015)

Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19
por: Hashem, Mai, et al.
Publicado: (2023)

Liver injury in COVID-19: The current evidence
por: Alqahtani, Saleh A, et al.
Publicado: (2020)

Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients
por: Naeem, Muhammad, et al.
Publicado: (2023)

Outcomes of Liver Transplant Recipients Infected with COVID-19 is Similar to Non- liver Transplant Patients
por: Kulkarni, Dr Anand V., et al.
Publicado: (2022)

COVID-19 and liver injury: An ongoing challenge
por: Papagiouvanni, Ioanna, et al.
Publicado: (2023)

COVID-19: Mitigation or suppression?
por: Kassem, Abdel Meguid
Publicado: (2020)

The impact of COVID-19 on liver injury in various age
por: Sadeghi Dousari, Amin, et al.
Publicado: (2023)

The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review
por: Mansour, Reham Osama, et al.
Publicado: (2023)

COVID-19: Gastrointestinal manifestations, liver injury and recommendations
por: Ozkurt, Zulal, et al.
Publicado: (2022)

COVID-19 and liver injury in individuals with obesity
por: Lempesis, Ioannis G, et al.
Publicado: (2023)

Consolidating food safety measures against COVID-19: a review
por: Abolmaaty, Assem, et al.
Publicado: (2022)

Catatonia after COVID-19 infection: scoping review
por: Dawood, Abdallah Samr, et al.
Publicado: (2023)

BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bystander?
por: Koneru, Gopala, et al.
Publicado: (2021)

Impact of COVID‐19 in Liver Disease Progression
por: Martinez, Miguel Angel, et al.
Publicado: (2021)

Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury
por: Siddiqui, Mohammad Arsalan, et al.
Publicado: (2021)

Pathophysiological mechanisms of liver injury in COVID‐19
por: Nardo, Alexander D., et al.
Publicado: (2020)

Bioactive glass doped with noble metal nanoparticles for bone regeneration: in vitro kinetics and proliferative impact on human bone cell line
por: Mostafa, Amany A., et al.
Publicado: (2021)

Liver injury in COVID-19: clinical features and treatment management
por: Yu, Dongdong, et al.
Publicado: (2021)

COVID-19-associated liver injury: from bedside to bench
por: Li, Dongxiao, et al.
Publicado: (2021)

Systemic risk: The impact of COVID-19()
por: Rizwan, Muhammad Suhail, et al.
Publicado: (2020)

COVID-19 and liver injury: where do we stand?
por: Papadopoulos, Nikolaos, et al.
Publicado: (2020)

Impact of insulin producing cells derived from adipose tissue mesenchymal stem cells on testicular dysfunction of diabetic rats
por: Abd El Kader, Mai A., et al.
Publicado: (2021)

Use of Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19) infection among Sudanese patients: a case series
por: Yousif, Maysoun, et al.
Publicado: (2022)

Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy
por: Gabrielli, Maurizio, et al.
Publicado: (2022)

Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury
por: Akkiz, Hikmet
Publicado: (2023)

Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9u2lnn2kfqigcd6mkd4tfgq3s3